Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

American Healthcare REIT

AHR Unknown Unknown Updated July 17, 2026
$57.17
49/100
AI Committee Verdict
Watch
Conviction: Contested · 50% agreement · 6 analysts
Contested
Is AHR Bullish or Bearish?
Mixed. Innellis AI committee rates American Healthcare REIT (AHR) Watch with a composite score of 49/100 , based on 6 analysts with 50% agreement. Last updated July 17, 2026.
Executive Summary
6 analysts weighed in with 50% agreement on a bearish lean. Macro Analyst: Market regime is bullish (Bull market -- normal position sizing). Value Analyst: P/E of 363.4 is expensive by classic value standards. Overall recommendation: WATCH.
Price History (6M)
AI Investment Committee
Committee Consensus As of July 17, 2026
Overall Committee Score
49/100
Agreement
50%
Analysts
6
Conviction
Contested
Value Analyst bearish
35 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 363.4 is expensive by classic value standards
Growth Analyst bearish
40 / 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.68 is tight -- limited short-term liquidity cushion
Macro Analyst bullish
70 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
60 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 5 existing position pair(s) are highly correlated already
Open Full Terminal →
Technical Analysis
Technical analysis data not yet available for AHR.
Fundamental Analysis
Valuation
P/E Ratio
P/B Ratio
PEG Ratio
Dividend Yield
52W High
52W Low
Quality & Growth
ROE
ROA
Gross Margin
Operating Margin
Revenue Growth YoY
Debt / Equity
Key Risks
Risk data not available for AHR.
Get the Full AHR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal → Mobile
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime